Rami Aboumourad, OD
Optometrist · Miami, FLNPI 1275191066
Payments from drug & device makers
Across 42 payments — averaging $245.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kedrion Biopharma, Inc.$6K
- Alcon$651
- Bausch & Lomb Americas Inc.$608
- Sun Pharmaceutical Industries Inc.$433
- Bausch & Lomb, A Division Of Bausch Health US, LLC$362
- Biotissue Holdings Inc.$279
- plus $2K from 10 others
What the payments were for
- Consulting fees$6,20660%
- Food & beverage$4,10340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kedrion Biopharma, Inc. | 4 | $6,435 |
| Alcon | 6 | $651 |
| Bausch & Lomb Americas Inc. | 5 | $608 |
| Sun Pharmaceutical Industries Inc. | 3 | $433 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $362 |
| Biotissue Holdings Inc. | 3 | $279 |
| Rxsight Inc | 2 | $276 |
| Dompe US, Inc. | 2 | $275 |
| AbbVie(2 entities) | 3 | $232 |
| Harrow Eye, LLC | 2 | $208 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $144 |
| Sight Sciences, Inc. | 3 | $142 |
| Oyster Point Pharma, Inc. | 1 | $121 |
| Astellas Pharma Global Development | 1 | $93 |
| Carl Zeiss Meditec, Inc. | 1 | $33 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Albuked$6,435
- KOATE$6,435
- GAMMAKED$6,435
- KEDRAB$6,435
- RhoGAM Ultra-Filtered PLUS$6,435
- CEQUA$433
- Clareon$391
- STELLARIS$384
- ULTRA$340
- RXSIGHT CONTACT LENS$276
- RXSIGHT INJECTOR CARTRIDGE$276
- RXSIGHT INJECTOR HANDPIECE$276
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$276
- Oxervate$275
- LIGHT ADJUSTABLE LENS (LAL)$163
- Prokera$148
- AmnioGraft$148
- AcrySof IQ PanOptix$124
- TYRVAYA$121
- VEVYE$120
How this compares
$10,309 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 12 | $5,330 |
| Prednisolone Acetate | 17 | $888 |
| ValacyclovirValacyclovir Hcl | 15 | $528 |
| Atropine Sulfate | 11 | $378 |
| ErythromycinErythromycin Base | 29 | $301 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $193 |
| Latanoprost | 14 | $90 |
| Azithromycin | 15 | $27 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Miami
- Mark DunbarMiami$236K
- Elise KramerMiami$172K
- Diana ShechtmanMiami$150K
- Angelica CifuentesMiami$68K
- Diana PerezMiami$56K
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.